Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹288 Cr
Revenue (TTM)
₹268 Cr
Net Profit (TTM)
₹8 Cr
ROE
20.2 %
ROCE
19 %
P/E Ratio
34.3
P/B Ratio
4.1
Industry P/E
20.86
EV/EBITDA
25.2
Div. Yield
0 %
Debt to Equity
0
Book Value
₹1.9
EPS
₹0.2
Face value
1
Shares outstanding
375,372,000
CFO
₹14.89 Cr
EBITDA
₹93.90 Cr
Net Profit
₹50.15 Cr
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
---|---|---|---|---|---|---|---|
MK Proteins
| -5.3 | 4.5 | 27.9 | -38.1 | -66.0 | -37.1 | -- |
BSE FMCG
| -3.2 | -3.7 | 5.6 | -2.5 | 14.7 | 13.2 | 10.3 |
BSE Small Cap
| -4.4 | 1.8 | 13.8 | 1.9 | 29.5 | 33.7 | 17.0 |
Company
|
2024
|
2023
|
2022
|
2018
|
---|---|---|---|---|
MK Proteins
| -66.1 | 12.6 | 1,750.2 | -9.5 |
BSE Small Cap
| 29.0 | 47.5 | -1.8 | -23.4 |
BSE FMCG
| 1.5 | 27.3 | 16.6 | 10.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
---|---|---|---|---|---|---|---|---|
MK Proteins
|
7.7 | 287.9 | 267.7 | 8.4 | 4.5 | 12.5 | 34.3 | 4.1 |
41.2 | 1,214.6 | 2,909.6 | 102.9 | 5.4 | 12.2 | 12.8 | 1.5 | |
448.7 | 1,255.6 | 1,029.0 | 41.2 | 9.2 | 2.1 | 30.5 | 0.7 | |
2.5 | 465.6 | 94.5 | 1.4 | 2.2 | 0.3 | 500.6 | 1.1 | |
292.0 | 4,299.4 | 19,553.1 | 245.7 | 2.4 | 25.2 | 17.5 | 4.2 | |
45.3 | 447.3 | 3,510.9 | 14.8 | 0.7 | 4.3 | 30.2 | 1.3 | |
115.8 | 578.2 | 734.3 | 37.0 | 5.8 | 18 | 15.6 | -- | |
14.7 | 481.8 | 2,281.5 | 23.1 | 1.8 | 12.6 | 20.9 | 2.4 | |
524.6 | 698.1 | 663.1 | 31.0 | 7.3 | 27.3 | 22.5 | 5.7 | |
892.5 | 285.7 | 1,830.7 | 18.4 | 1.3 | 5.4 | 15.5 | 0.8 |
No Review & Analysis are available.
--
Incorporated
2012
Chairman
Parvind Kumar
Managing Director
Parmod Kumar
Headquarters
Ambala, Haryana
Website
Looking for more details about MK Proteins Ltd.’s IPO? Explore our IPO Details page.
Annual Reports
The total asset value of MK Proteins Ltd stood at ₹ 131 Cr as on 31-Mar-25
The share price of MK Proteins Ltd is ₹7.71 (NSE) and ₹7.67 (BSE) as of 20-Jun-2025 IST. MK Proteins Ltd has given a return of -65.99% in the last 3 years.
MK Proteins Ltd has a market capitalisation of ₹ 288 Cr as on 20-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of MK Proteins Ltd is 4.14 times as on 20-Jun-2025, a 107% premium to its peers’ median range of 2.00 times.
The P/E ratio of MK Proteins Ltd is 34.29 times as on 20-Jun-2025, a 64% premium to its peers’ median range of 20.86 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the MK Proteins Ltd and enter the required number of quantities and click on buy to purchase the shares of MK Proteins Ltd.
The prominent promoters of MK Proteins Ltd. are
Name of promoters | Holding percentage |
---|---|
PRAGUN GARG |
6.33%
|
VINOD KUMAR HUF |
6.23%
|
RAJ KUMAR GARG |
6.19%
|
SHIVANI GARG |
6.11%
|
SUNILA GARG |
5.71%
|
The chairman of the company is Parvind Kumar, and the managing director is Parmod Kumar.
There is no promoter pledging in MK Proteins Ltd.
Some of the close peers are:
Company | Market Cap(₹ Cr) |
---|---|
4,299
|
|
1,256
|
|
1,215
|
|
698
|
|
578
|
|
482
|
|
466
|
|
447
|
|
286
|
MK Proteins Ltd. | Ratios |
---|---|
Return on equity(%)
|
12.46
|
Operating margin(%)
|
4.51
|
Net Margin(%)
|
3.13
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of MK Proteins Ltd was ₹8 Cr.